The estimated Net Worth of James Edward Bass is at least $2.6 Milion dollars as of 5 March 2019. James Bass owns over 5,852 units of Reata Pharmaceuticals Inc stock worth over $2,017,129 and over the last 8 years James sold RETA stock worth over $586,897.
James has made over 9 trades of the Reata Pharmaceuticals Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently James sold 5,852 units of RETA stock worth $586,897 on 5 March 2019.
The largest trade James's ever made was buying 23,000 units of Reata Pharmaceuticals Inc stock on 1 June 2016 worth over $264,500. On average, James trades about 3,391 units every 63 days since 2016. As of 5 March 2019 James still owns at least 11,703 units of Reata Pharmaceuticals Inc stock.
You can see the complete history of James Bass stock trades at the bottom of the page.
James's mailing address filed with the SEC is 2801 Gateway Dr #150, Irving, TX 75063, USA.
Over the last 8 years, insiders at Reata Pharmaceuticals Inc have traded over $176,850,875 worth of Reata Pharmaceuticals Inc stock and bought 8,443,489 units worth $179,313,590 . The most active insiders traders include Holdings A/S Novo, R Kent Jr Mc Gaughy oraz Inc Cpmg. On average, Reata Pharmaceuticals Inc executives and independent directors trade stock every 16 days with the average trade being worth of $10,950,893. The most recent stock trade was executed by Andrea Loewen on 14 September 2023, trading 3,175 units of RETA stock currently worth $546,195.
reata pharmaceuticals, inc. (nasdaq:reta) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
Reata Pharmaceuticals Inc executives and other stock owners filed with the SEC include: